Cargando…

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse

Detalles Bibliográficos
Autores principales: Diener, HC, Dodick, DW, DeGryse, RE, Turkel, CC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620307/
http://dx.doi.org/10.1186/1129-2377-1-S14-P204
_version_ 1782265572073930752
author Diener, HC
Dodick, DW
DeGryse, RE
Turkel, CC
author_facet Diener, HC
Dodick, DW
DeGryse, RE
Turkel, CC
author_sort Diener, HC
collection PubMed
description
format Online
Article
Text
id pubmed-3620307
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-36203072013-09-20 OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse Diener, HC Dodick, DW DeGryse, RE Turkel, CC J Headache Pain Poster Presentation Springer 2013 2013-02-21 /pmc/articles/PMC3620307/ http://dx.doi.org/10.1186/1129-2377-1-S14-P204 Text en Copyright ©2013 Diener et al; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Diener, HC
Dodick, DW
DeGryse, RE
Turkel, CC
OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
title OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
title_full OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
title_fullStr OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
title_full_unstemmed OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
title_short OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
title_sort onabotulinumtoxina for treatment of chronic migraine: preempt 24-week pooled subgroup analysis of patients without medication overuse
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620307/
http://dx.doi.org/10.1186/1129-2377-1-S14-P204
work_keys_str_mv AT dienerhc onabotulinumtoxinafortreatmentofchronicmigrainepreempt24weekpooledsubgroupanalysisofpatientswithoutmedicationoveruse
AT dodickdw onabotulinumtoxinafortreatmentofchronicmigrainepreempt24weekpooledsubgroupanalysisofpatientswithoutmedicationoveruse
AT degrysere onabotulinumtoxinafortreatmentofchronicmigrainepreempt24weekpooledsubgroupanalysisofpatientswithoutmedicationoveruse
AT turkelcc onabotulinumtoxinafortreatmentofchronicmigrainepreempt24weekpooledsubgroupanalysisofpatientswithoutmedicationoveruse